Document is current

Article History

Accepted: 19 May 2021

First Online: 23 June 2021

Declarations

:

: Support for this work was provided by AstraZeneca UK Ltd., who provided funding for medical writing. AstraZeneca UK Ltd. has reviewed this document for factual accuracy only.

: ME reports honoraria from AstraZeneca, NovoNordisk, Takeda and NAPP, and research support from NovoNordisk outside the submitted work. Marc Evans received financial support for consultancy from Novartis, Merck Sharp & Dohme Corp. and Novo Nordisk, and has served on the speaker’s bureau for Novartis, Lilly, Boehringer lngelheim, Merck Sharp & Dohme Corp., Novo Nordisk, Janssen and Takeda. ARM is an employee of Health Economics and Outcomes Research Ltd., Cardiff, UK, who received fees from AstraZeneca in relation to this study. ZY reports personal fees from AstraZeneca, personal fees from Lilly, personal fees from Boehringer Ingelheim and personal fees from Novartis outside the submitted work. GE has received honoraria for lectures from AstraZeneca, Boehringer Ingelheim, Bayer, Pfizer. UD reports personal fees from AstraZeneca, Napp, Sanofi, BI, Lilly and Novo Nordisk, outside the submitted work. DCP reports personal fees from AstraZeneca, personal fees from Boehringer Ingelheim, personal fees from Eli Lilly, non-financial support from Napp, personal fees from Novo Nordisk, personal fees from MSD, personal fees and non-financial support from Sanofi outside the submitted work. In addition, DCP is an executive committee member of the Association of British Clinical Diabetologists and member of the CaReMe UK group. PB reports personal fees and non-financial support from Abbott, personal fees and non-financial support from AstraZeneca, personal fees and non-financial support from Boehringer Ingelheim, personal fees and non-financial support from Eli Lilly, personal fees and non-financial support from Janssen, personal fees and non-financial support from MSD, personal fees and non-financial support from Napp, personal fees and non-financial support from Novo Nordisk, personal fees, non-financial support and other from Primary Care Diabetes Society, personal fees and non-financial support from iHeed/University of Warwick, and personal fees and non-financial support from Diabetes UK, outside the submitted work. WH reports grants and personal fees from AstraZeneca, grants and personal fees from Boehringer Ingelheim, grants and personal fees from NAPP, from MSD, outside the submitted work. JNT has nothing to disclose. NK reports personal fees from AstraZeneca, personal fees from Boehringer Ingelheim, personal fees from Lilly, personal fees from Sanofi, personal fees from Mylan, personal fees from Roche, personal fees from ABBOTT, and personal fees from Napp outside the submitted work. JM has received honoraria from AstraZeneca, Boehringer Ingelheim and Novartis for various activities including attending and participating in educational events and advisory boards. JPHW reports grants, personal fees and other from AstraZeneca, other from Astellas, personal fees and other from Boehringer Ingelheim, other from Janssen, personal fees and other from Napp, grants, personal fees and other from Novo Nordisk, personal fees and other from Mundipharma, other from Sanofi, grants and personal fees from Takeda, other from Rhythm Pharmaceuticals, other from Wilmington Healthcare, other from Eli Lilly, outside the submitted work. SCB reports personal fees and other from Abbott, personal fees and other from AstraZeneca, personal fees and other from Boehringer Ingelheim, personal fees and other from Cellnovo, personal fees and other from Eli Lilly, personal fees and other from Merck Sharp & Dohme, personal fees and other from Novo Nordisk, personal fees and other from Sanofi-Aventis, other from Cardiff University, other from Doctors.net, other from Elsevier, other from Onmedica, other from Omnia-Med, other from Medscape, other from All-Wales Medicines Strategy Group, other from National Institute for Health and Care Excellence (NICE) UK, and other from Glycosmedia, outside the submitted work.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: ME and ARM researched data for the article, contributed to discussion of content, wrote the article and reviewed and edited the manuscript before submission. ZY, GE, UD, DCP, PB, WH, JNT, NK, JM, JPHW and SCB contributed to discussion of content and reviewed and edited the manuscript before submission. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.